Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 6, 1999, Pages 835-838

  Soman, A ^a   Honeybourne, D ^a,b   Andrews, J ^a   Jevons, G ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTICLE; ASSAY; BRONCHUS MUCOSA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG PENETRATION; FEMALE; FIBEROPTIC BRONCHOSCOPY; HAEMOPHILUS INFLUENZAE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; ORAL DRUG ADMINISTRATION; STREPTOCOCCUS PNEUMONIAE; TIME; TISSUE LEVEL;

EID: 0032787042     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.6.835     Document Type: Article

References (10)

1. Klugman, K. P. & Capper, T. (1997). Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin. Journal of Antimicrobial Chemotherapy 40, 797-802.
2. Wise, R. & Honeybourne, D. (1996). A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 57-63.
3. Honeybourne, D., Andrews, J. M., Ashby, J. P., Lodwick, R. & Wise, R. (1988). Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa. Thorax 43, 715-9.
4. Bennet, J. V., Brodie, J. L., Benner, E. J. & Kirby, W. M. (1966). Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiology 14, 170-7.
5. Johnson, J. D., Hand, W. L., Francis, J. B., King-Thompson, N. L. & Corwin, R. W. (1980). Antibiotic uptake by alveolar macrophages. Journal of Laboratory and Clinical Medicine 95, 429-39.
6. Rennard, S. I., Basset, G., Lecossier, D., O'Donnell, K. M., Pinkston, P., Martin, P. et al. (1986). Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. Journal of Applied Physiology 60, 532-8.
7. Woodcock, J. M., Andrews, J. M., Boswell, F. J., Brenwald, N. P. & Wise, R. (1997). In-vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 41, 101-6.
8. Renaudin, H., Bebear, D. & Boudjadja, A. (1996). In-vitro activity of BAY 12-8039, a new fluoroquinolone, against mycoplasmas. In Programme and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy. Poster, Abstract F9.
9. Andrews, J. M., Honeybourne, D., Brenwald, N. P., Bannerjee, D., Iredale, M., Cunningham, B. et al. (1997). Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy 39, 797-802.
10. Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C. & Schentag, J. J. (1993). The pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37, 1073-81.